70619-50-0 Usage
General Description
4-(4-Ethoxycarbonylphenyl)-3-thiosemicarbazide is a chemically synthesized compound that displays various chemical properties and activities. It belongs to the class of thiosemicarbazides, a group of organic compounds characterized by the presence of a thiosemicarbazide core, itself comprising a thiourea (an organic compound of carbon, nitrogen, sulfur and hydrogen) bearing an amino substituent. Due to its chemical structure, it often participates in reactions that involve the formation or modification of other chemical substances. As such, it is commonly used in research for the development and testing of novel chemical reactions and pathways. Its exact properties and effects can vary depending on factors such as concentration, temperature, and the presence of other chemicals in its environment.
Check Digit Verification of cas no
The CAS Registry Mumber 70619-50-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,6,1 and 9 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 70619-50:
(7*7)+(6*0)+(5*6)+(4*1)+(3*9)+(2*5)+(1*0)=120
120 % 10 = 0
So 70619-50-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N3O2S/c1-2-15-9(14)7-3-5-8(6-4-7)12-10(16)13-11/h3-6H,2,11H2,1H3,(H2,12,13,16)
70619-50-0Relevant articles and documents
Synthesis and anticonvulsant and neurotoxicity evaluation of N 4-phthalimido phenyl (thio) semicarbazides
Yogeeswari,Sriram,Saraswat,Ragavendran, J. Vaigunda,Kumar, M. Mohan,Murugesan,Thirumurugan,Stables
, p. 341 - 346 (2007/10/03)
The phenyl (thio) semicarbazide derivatives of phthalimido pharmacophore were synthesized and evaluated for their anticonvulsant and neurotoxic properties. Initial anticonvulsant screening was performed using intraperitoneal (i.p.), maximal electroshock-induced seizure (MES), subcutaneous pentylenetetrazole (scPTZ) and subcutaneous strychnine (sc STY)-induced seizure threshold tests in mice. Compound 2c afforded protection in all the three screens. Compounds except 1d, 2a and 2d showed no neurotoxicity up to 300mg/kg. Compounds 1a, 1b, 2c, 2d, 2g and 2i were found to show oral MES activity. The compounds exhibited CNS depression and behavioral despair side effects, lesser than the conventional antiepileptic drugs.
